These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 26669609)
1. Effects of RNA interference therapy against herpes simplex virus type 1 encephalitis. da Silva AS; Raposo JV; Pereira TC; Pinto MA; de Paula VS Antivir Ther; 2016; 21(3):225-35. PubMed ID: 26669609 [TBL] [Abstract][Full Text] [Related]
2. Favorable effects of MMP-9 knockdown in murine herpes simplex encephalitis using small interfering RNA. Zhou Y; Lu ZN; Guo YJ; Mei YW Neurol Res; 2010 Oct; 32(8):801-9. PubMed ID: 20483026 [TBL] [Abstract][Full Text] [Related]
3. Herpes simplex encephalitis : from virus to therapy. Rozenberg F; Deback C; Agut H Infect Disord Drug Targets; 2011 Jun; 11(3):235-50. PubMed ID: 21488834 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools. Paavilainen H; Lehtinen J; Romanovskaya A; Nygårdas M; Bamford DH; Poranen MM; Hukkanen V J Med Virol; 2016 Dec; 88(12):2196-2205. PubMed ID: 27191509 [TBL] [Abstract][Full Text] [Related]
5. [Diagnostic and therapeutic strategy for acyclovir-resistant herpes encephalitis]. Saijo M Rinsho Shinkeigaku; 2014; 54(12):1024-7. PubMed ID: 25672698 [TBL] [Abstract][Full Text] [Related]
6. A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis. Uyar O; Plante PL; Piret J; Venable MC; Carbonneau J; Corbeil J; Boivin G Sci Rep; 2021 Sep; 11(1):18688. PubMed ID: 34548521 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of herpes simplex virus type 1 by small interfering RNA. Zhang YQ; Lai W; Li H; Li G Clin Exp Dermatol; 2008 Jan; 33(1):56-61. PubMed ID: 17979991 [TBL] [Abstract][Full Text] [Related]
9. Enhanced viral clearance and reduced leukocyte infiltration in experimental herpes encephalitis after intranasal infection of CXCR3-deficient mice. Zimmermann J; Hafezi W; Dockhorn A; Lorentzen EU; Krauthausen M; Getts DR; Müller M; Kühn JE; King NJC J Neurovirol; 2017 Jun; 23(3):394-403. PubMed ID: 28116674 [TBL] [Abstract][Full Text] [Related]
10. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis. Uyar O; Laflamme N; Piret J; Venable MC; Carbonneau J; Zarrouk K; Rivest S; Boivin G J Virol; 2020 Nov; 94(23):. PubMed ID: 32938766 [TBL] [Abstract][Full Text] [Related]
11. Silencing herpes simplex virus type 1 capsid protein encoding genes by siRNA: a promising antiviral therapeutic approach. Jin F; Li S; Zheng K; Zhuo C; Ma K; Chen M; Wang Q; Zhang P; Fan J; Ren Z; Wang Y PLoS One; 2014; 9(5):e96623. PubMed ID: 24794394 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated shRNA interference against HSV-1 replication in vitro. Song B; Liu X; Wang Q; Zhang R; Yang T; Han Z; Xu Y J Neurovirol; 2016 Dec; 22(6):799-807. PubMed ID: 27566181 [TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Tyler KL Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091 [TBL] [Abstract][Full Text] [Related]
16. Effect of resveratrol on herpesvirus encephalitis: Evidences for its mechanisms of action. Huang Z; Li S; Zhong L; Su Y; Li M; Wang X; Wang Z; Wang Z; Ye C; Ren Z; Wang X; Zeng Q; Zheng K; Wang Y Phytomedicine; 2024 May; 127():155476. PubMed ID: 38430586 [TBL] [Abstract][Full Text] [Related]
17. The combination of valacyclovir with an anti-TNF alpha antibody increases survival rate compared to antiviral therapy alone in a murine model of herpes simplex virus encephalitis. Boivin N; Menasria R; Piret J; Rivest S; Boivin G Antiviral Res; 2013 Dec; 100(3):649-53. PubMed ID: 24416771 [TBL] [Abstract][Full Text] [Related]
18. [Protective effect of Forsythiae Fructus extract on mice with herpes simplex encephalitis]. Wang Y; Zhou J; Yuan MM; Zheng XH; Zhang L Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(11):3023-3028. PubMed ID: 35718526 [TBL] [Abstract][Full Text] [Related]
19. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge. Osorio Y; Ghiasi H J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224 [TBL] [Abstract][Full Text] [Related]
20. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent. Lundberg P; Openshaw H; Wang M; Yang HJ; Cantin E Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4162-70. PubMed ID: 17724202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]